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background: Antisynthetase (AS) syndrome is characterized by idiopathic inflammatory myopathy, interstitial lung disease, cutaneous involvement, 
arthritis, fever, and antibody specificity. Cardiac involvement is extremely rare, with few case reports to date describing only right ventricular 
compromise and aortic valve involvement.
case:  A previously healthy 44 year old bodybuilder developed 3 months of unexpected weight loss and peripheral edema. He was lost to follow 
up and presented after one year with symptoms of heart failure (HF) and progressive proximal muscle weakness. Physical examination revealed a 
fatigued African American male who was dyspneic at rest, with signs of acute decompensated HF including elevated jugular venous pressure, ascites, 
massive peripheral edema, and an S3 gallop. He had bilateral upper and lower extremity proximal muscle weakness. Skin examination revealed 
“mechanic’s hands”.
Decision making: His rapidly progressive muscle weakness was concerning for myositis. Laboratory studies revealed elevations of serum creatine 
kinase, lactate dehydrogenase, aldolase, CK-MB, and cardiac troponin I. Magnetic resonance imaging, electromyography, and skeletal muscle 
biopsy of the lower extremities were consistent with myositis. As part of an extensive serological work up, antisynthetase antibodies were obtained 
from which Anti-Jo1 antibody was positive, confirming the diagnosis of antisynthetase syndrome. Echocardiography showed severe enlargement of 
all cardiac chambers with marked biventricular dysfunction. Endomyocardial biopsy revealed active myocarditis. He required inotropic therapy and 
intravenous diuresis for his HF, and was initiated on pulse dose steroids. He showed marked improvement in muscle strength and exercise tolerance 
by discharge and was transitioned to prednisone and methotrexate. At 6 months he had full recovery of muscle weakness and improvement in HF 
symptoms.
conclusion: To our knowledge, this is the first case of AS syndrome-associated myocarditis and fulminant HF. Based on these observations, we 
suggest that myocarditis should be considered and evaluated for in patients with AS syndrome presenting with HF.
